Healthcare Professionals
Cardioblate™ Gemini
Irrigated RF Surgical Ablation System
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Healthcare Professionals
Cardioblate™ Gemini
Irrigated RF Surgical Ablation System
Irrigated radiofrequency for effective box lesions in beating heart concomitant and standalone AF procedures.
Summary
The Medtronic Cardioblate™ Gemini™-S Surgical Ablation System combines the efficacy of irrigated RF energy with a bipolar design to create clamped box lesions in open and minimally invasive procedures.
The Gemini-S model features:
The bipolar irrigated RF box-lesion is a safe and effective procedure for minimally invasive treatment of stand-alone AF.1
Thoracoscopic PVI and box isolation is highly effective in restoring sinus rhythm in long-standing persistent AF, reaching a success rate of more than 90% after 12 months.2
The box lesions created by the irrigated Bipolar Gemini™-s clamp provide a more effective isolation of the posterior left atrium wall and pulmonary veins when compared to the non-clamping box lesion with non-irrigated Isolator®* Synergy™* and Coolrail®* Linear Pen, (Atricure, Inc.). In fact, repeat catheter interventions were required in only 10% of Gemini™-s procedures versus 21% of Isolator®* Synergy™* and Coolrail®* Linear Pen, (Atricure, Inc.).2
These findings are consistent with a recent study in which complete isolation of the posterior Left Atrial Wall was only achieved in 23% of the patients treated with Isolator®* Synergy™* and Coolrail®* Linear Pen (AtriCure, Inc.) and the majority of patients required endocardial catheter ablation to complete the linear ablation lesions.3
Possible complications related to the ablation of cardiac tissue in combination with open heart surgery are: tissue perforation, extension of extracorporeal bypass, perioperative heart rhythm disturbances (atrial and/or ventricular), postoperative embolic complications, pericardial effusion or tamponade, injury to the great vessels, valve leaflet damage, conductions disturbances (SA/AV node), acute ischemic myocardial event and thrombus formation.
This product may not be available in your region. Please contact your Medtronic representative to determine availability in your area.
™*Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
1 Thoracoscopic radiofrequency ablation for lone atrial fibrillation: Box-lesion technique. Ales Klvacek et al. coretvasa 59 (2017) e332 – e336.
2 Clamping vs Non-Clamping Thoracoscopic Box Ablation in Long-Standing Persistent Atrial Fibrillation. Niels Harlaar, BSc, Niels J. Verberkmoes, MD, Pepijn H. van der Voort, MD, Serge A. Trines, MD, PhD, Stefan E. Verstraeten, MD, Bart J.A. Mertens, PhD, Robert J.M. Klautz, MD, PhD, Jerry Braun, MD, PhD, Thomas J. van Brakel, MD, PhD. S0022- 5223(19)31672-1.
3 Bulava A et al.: Correlates of Arrhythmia Recurrence After Hybrid Epi- and Endocardial Radiofrequency Ablation for Persistent Atrial Fibrillation. (Circ Arrhythm Electrophysiol. 2017;10:e005273. OI:0.1161/CIRCEP.117.005273.